Browse by author
Lookup NU author(s): Professor Miles Whittington
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Studies of psychiatric disorders have traditionally focused on emotional symptoms such as depression, anxiety and hallucinations. However, poorly controlled cognitive deficits are equally prominent and severely compromise quality of life, including social and professional integration. Consequently, intensive efforts are being made to characterize the cellular and cerebral circuits underpinning cognitive function, define the nature and causes of cognitive impairment in psychiatric disorders and identify more effective treatments. Successful development will depend on rigorous validation in animal models as well as in patients, including measures of real-world cognitive functioning. This article critically discusses these issues, highlighting the challenges and opportunities for improving cognition in individuals suffering from psychiatric disorders.
Author(s): Millan MJ, Agid Y, Brune M, Bullmore ET, Carter CS, Clayton NS, Connor R, Davis S, Deakin B, DeRubeis RJ, Dubois B, Geyer MA, Goodwin GM, Gorwood P, Jay TM, Joels M, Mansuy IM, Meyer-Lindenberg A, Murphy D, Rolls E, Saletu B, Spedding M, Sweeney J, Whittington M, Young LJ
Publication type: Review
Publication status: Published
Journal: Nature Reviews Drug Discovery
Year: 2012
Volume: 11
Issue: 2
Pages: 141-168
Print publication date: 01/02/2012
ISSN (print): 1474-1776
ISSN (electronic): 1474-1784
Publisher: NATURE PUBLISHING GROUP
URL: http://dx.doi.org/10.1038/nrd3628
DOI: 10.1038/nrd3628